AssetMark Inc’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.1M Buy
38,805
+6,104
+19% +$2.58M 0.03% 449
2026
Q1
$15.5M Buy
32,701
+11,153
+52% +$5.61M 0.03% 388
2025
Q4
$10.1M Buy
21,548
+10,150
+89% +$4.71M 0.02% 495
2025
Q3
$4.86M Sell
11,398
-33
-0.3% -$12.8K 0.01% 629
2025
Q2
$4.38M Buy
11,431
+1,558
+16% +$561K 0.01% 616
2025
Q1
$3.41M Sell
9,873
-63
-0.6% -$20.3K 0.01% 600
2024
Q4
$2.98M Buy
9,936
+8,102
+442% +$2.83M 0.01% 624
2024
Q3
$746K Buy
1,834
+96
+6% +$35.1K ﹤0.01% 833
2024
Q2
$558K Buy
1,738
+347
+25% +$113K ﹤0.01% 858
2024
Q1
$464K Sell
1,391
-104
-7% -$31.8K ﹤0.01% 840
2023
Q4
$405K Buy
1,495
+323
+28% +$79.8K ﹤0.01% 821
2023
Q3
$288K Sell
1,172
-120
-9% -$32.8K ﹤0.01% 820
2023
Q2
$392K Sell
1,292
-74
-5% -$20.6K ﹤0.01% 761
2023
Q1
$360K Sell
1,366
-275
-17% -$69.9K ﹤0.01% 757
2022
Q4
$394K Sell
1,641
-11
-0.7% -$2.46K ﹤0.01% 734
2022
Q3
$304K Sell
1,652
-145
-8% -$28.9K ﹤0.01% 721
2022
Q2
$302K Buy
1,797
+183
+11% +$39.3K ﹤0.01% 694
2022
Q1
$405K Sell
1,614
-210
-12% -$52.7K ﹤0.01% 642
2021
Q4
$469K Buy
1,824
+11
+0.6% +$2.69K ﹤0.01% 552
2021
Q3
$440K Sell
1,813
-32
-2% -$7.82K ﹤0.01% 472
2021
Q2
$381K Buy
1,845
+12
+0.7% +$2.45K ﹤0.01% 492
2021
Q1
$345K Buy
1,833
+83
+5% +$14.6K ﹤0.01% 489
2020
Q4
$288K Sell
1,750
-97
-5% -$14.2K ﹤0.01% 504
2020
Q3
$230K Buy
1,847
+46
+3% +$5.69K ﹤0.01% 503
2020
Q2
$175K Sell
1,801
-262
-13% -$27.2K ﹤0.01% 510
2020
Q1
$185K Sell
2,063
-102
-5% -$13.2K ﹤0.01% 503
2019
Q4
$320K Sell
2,165
-89,794
-98% -$12.1M ﹤0.01% 463
2019
Q3
$11.1M Buy
91,959
+2,371
+3% +$306K 0.09% 187
2019
Q2
$12.1M Buy
89,588
+5,518
+7% +$698K 0.1% 165
2019
Q1
$11M Buy
84,070
+3,349
+4% +$450K 0.1% 168
2018
Q4
$10M Buy
+80,721
New +$10.8M 0.1% 163
2018
Q1
Sell
-198
Closed -$17K 1651
2017
Q4
$17K Buy
198
+154
+350% +$12.4K ﹤0.01% 1023
2017
Q3
$4K Sell
44
-63
-59% -$5.07K ﹤0.01% 1171
2017
Q2
$9K Buy
+107
New +$9.05K ﹤0.01% 1040
2017
Q1
Sell
-3
Closed 1339
2016
Q4
$0 Sell
3
-51
-94% -$3.82K ﹤0.01% 1306
2016
Q3
$4K Sell
54
-240
-82% -$18.4K ﹤0.01% 1061
2016
Q2
$23K Sell
294
-30
-9% -$2.37K ﹤0.01% 814
2016
Q1
$25K Sell
324
-664
-67% -$46.4K ﹤0.01% 717
2015
Q4
$67K Buy
988
+927
+1,520% +$64.7K ﹤0.01% 557
2015
Q3
$5K Sell
61
-7
-10% -$620 ﹤0.01% 562
2015
Q2
$6K Buy
+68
New +$5.45K ﹤0.01% 561

Other funds holding HCA

AssetMark Inc's HCA Position: Q2 2026 in Review

AssetMark Inc increased its HCA Healthcare (HCA) stake by 19% in Q2 2026, buying an estimated $2.58M and bringing the position to 38,805 shares worth $15.1M. The position accounts for 0.03% of the portfolio, ranked #449.

AssetMark Inc first reported a position in HCA in Q2 2015 and has held it in 41 quarters since. The position peaked at $15.5M in Q1 2026. 519 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • AssetMark Inc held 38,805 shares of HCA Healthcare worth $15.1M as of Q2 2026.
  • AssetMark Inc bought 6,104 HCA Healthcare shares in Q2 2026, an estimated $2.58M.
  • HCA Healthcare made up 0.03% of AssetMark Inc's portfolio in Q2 2026, its #449 holding.
  • AssetMark Inc first reported a position in HCA Healthcare in Q2 2015 and has held it in 41 quarters since.
  • AssetMark Inc's HCA Healthcare position peaked at $15.5M in Q1 2026.
  • 519 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.